Cytonics Corporation
Filings
64
Latest
1-SA · Sep 2026
Min Invest
—
Is this your company or fund? Claim this page free, or verify it and carry the Verified Issuer mark.
AltStreet Analysis
·Generated from EDGAR primary sources
Cytonics Corporation is a Florida-organized operating company that qualified a Tier 2 Regulation A offering of $19.0M in aggregate (est. net proceeds $17.1M), with D. Brooks and Associates CPA's, P.A. named as auditor and audited financials on file as required for Tier 2. The Part I snapshot shows a small operating business with $365K revenue, a net loss of roughly $977K, $1.1M total assets, $538K cash, $1.1M long-term debt, and only 1 full-time employee. The corpus shows the offering circular was qualified (253G2) and amended twice in 2020, but no subsequent 1-K or 1-SA annual/semiannual reports appear in the filing footprint, so ongoing Tier 2 reporting cannot be confirmed as continuing.
This is a direct-to-retail Regulation A Tier 2 offering, a format that allows non-accredited investors to participate without the suitability limits of Reg D, subject to SEC qualification of the offering circular and ongoing periodic reporting obligations.
Data Flags
Critical Disclosures
What the filings and the regulators have said about this entity that a reader should know first. Each line links to its source. The history, the same event across other issuers, and alerts are in the terminal.
Semi-annual financial statements for the period ended June 30, 2026, unaudited
Going concern: substantial doubt raised in the statements or the auditor's report. The figures are in the terminal.
EDGAR Filing Data
Form 1-A — Primary Source
View on SEC.govFilings on Record
Every filing AltStreet's ledger holds for this CIK, newest first (15 of 64). Each opens the SEC archive folder.
In the Terminal
Filing events
45
latest Sep 21, 2026
Critical / warning
0 / 0
8 watch · 37 info
Statements extracted
7
through Jun 30, 2026
NAV prints
0
none on file
Offering chains
12
reporting, funded, lapsed, terminated, exited
Latest event Semiannual report · Sep 21, 2026
SEC.govInvestor
- The dated record: 71 facts with source, effective date and capture date, viewable as AltStreet knew them on any past day
- 7 extracted financial statements: assets, liabilities, equity, revenue, net income, cash, latest for the period ended 2026-06-30
- 45 filing events with values and deltas, latest 2026-09-21, and alerts on the next one
- 12 offering timelines: velocity, share raised, first-sale lag, stalled flags
Pro
- This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
- The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV
Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…
Auditor of Record
As named on this issuer's SEC filings · Audited · see all issuers this firm audits
Is this your company or fund?
Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.
Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.